Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation

Lei Ying1, Anne B Hofseth, Darren D Browning

  • 1Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, School of Medicine, University of South Carolina, Columbia, South Carolina 29208, USA.

Cancer Research
|October 3, 2007
PubMed

Insights

Nitric oxide (NO) species promote colon cancer in inflammatory bowel disease by inactivating the retinoblastoma protein (pRb), increasing cell proliferation. This NO-driven pathway offers potential targets for preventing inflammation-induced cancer.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Cancer Research

Background:

  • Patients with chronic inflammatory bowel disease (IBD) face an elevated risk of colon cancer.
  • The specific molecular mechanisms driving colon cancer initiation and progression in IBD remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular pathways linking inflammation to colon cancer in IBD.
  • To identify key molecules involved in the inflammation-to-cancer sequence.

Main Methods:

  • Utilized in vitro cell models and a mouse model of colitis.
  • Investigated the role of nitric oxide (NO) species in cellular proliferation and protein regulation.

Main Results:

  • Nitric oxide (NO) species were found to induce hyperphosphorylation and inactivation of the retinoblastoma protein (pRb).
  • This inactivation activates the pRb-E2F1 pathway, leading to increased cell proliferation.
  • NO-driven pRb hyperphosphorylation is mediated by soluble guanylyl cyclase/cyclic GMP signaling and involves MEK/ERK and PI3K/AKT pathways.

Conclusions:

  • Established a direct link between nitric oxide (NO) and the inactivation of retinoblastoma protein (pRb).
  • Identified specific signaling pathways (sGC/cGMP, MEK/ERK, PI3K/AKT) involved in NO-induced pRb inactivation.
  • Provided crucial insights into molecular targets for preventing colon cancer in the context of chronic inflammation.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...